{
  "id": "d05eef16c39ae571",
  "title": "REZOLVE - AA Phase 2b Study of Rezpegaldesleukin Establishes Proof - of - Concept in Patients with Severe - to - Very - Severe Alopecia Areata",
  "description": "20251216T130000Z",
  "content": "",
  "source": "prnewswire.com",
  "source_url": "http://www.prnewswire.com/news-releases/rezolve-aa-phase-2b-study-of-rezpegaldesleukin-establishes-proof-of-concept-in-patients-with-severe-to-very-severe-alopecia-areata-302643167.html",
  "published_at": "20251216T130000Z",
  "fetched_at": "2025-12-17T00:22:43.797460+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "opec"
  ],
  "location": "United States",
  "raw_data": {
    "url": "http://www.prnewswire.com/news-releases/rezolve-aa-phase-2b-study-of-rezpegaldesleukin-establishes-proof-of-concept-in-patients-with-severe-to-very-severe-alopecia-areata-302643167.html",
    "url_mobile": "",
    "title": "REZOLVE - AA Phase 2b Study of Rezpegaldesleukin Establishes Proof - of - Concept in Patients with Severe - to - Very - Severe Alopecia Areata",
    "seendate": "20251216T130000Z",
    "socialimage": "",
    "domain": "prnewswire.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}